Amarin Reports Potential Legacy Effect of Icosapent Ethyl in New REDUCE-IT Analysis
Dublin, Ireland & Bridgewater, N.J. – August 28, 2026 Amarin Corporation announced new post hoc findings from the landmark...
Clinical Research
Advertisement
Leo Cancer Care and GE HealthCare Advance Radiation Therapy
MIDDLETON, WISCONSIN, Aug 28, 2026 Leo Cancer Care has announced a commercial collaboration with GE HealthCare to explore the...
AES Cleanroom Technology Gains FM 4882 Approval
MONTGOMERYVILLE, PENNSYLVANIA, Aug 27, 2026 AES Cleanroom Technology announced that its modular cleanroom wall and ceiling panel system has...
Fresenius Medical Care Reports Lower Mortality With HDF
BAD HOMBURG, GERMANY, Aug 27, 2026 Fresenius Medical Care has announced the publication of a large multinational real-world evidence...
Caris Life Sciences Links AI to Longer Survival in Pancreatic Cancer
Irving, Texas, United States, Aug 27, 2026 Caris Life Sciences has announced the publication of a study in npj...
Advertisements
Implantica Wins FDA Approval for RefluxStop® in U.S.
Stockholm, Sweden, August 21, 2026 Implantica AG has announced a major U.S. regulatory milestone after the U.S. Food and...
C2N PrecivityAD2 FDA Clearance Advances Alzheimer’s Testing
NEW YORK, August 21, 2026 The U.S. Food and Drug Administration (FDA) has cleared C2N Diagnostics’ PrecivityAD2 blood test,...
Raintree Expands Agentic AI for Rehab Therapy
Austin, Texas, August 20, 2026 Raintree Systems has expanded its agentic artificial intelligence (AI) platform for rehabilitation therapy, introducing...
Vascarta Begins Phase I Study of VAS-101 in SCD
Summit, New Jersey, August 20, 2026 Vascarta Inc. has announced the initiation of a Phase I clinical study of...
Arcato Reports Phase 1 Results for ARC-001 Gel
Greenville, North Carolina, August 19, 2026 Arcato Laboratories, Inc. has announced positive topline results from its first-in-human Phase 1...
Advertisement
